CNS Pharmaceuticals, Inc. (CNSP)
2.275
-0.11
(-4.80%)
USD |
NASDAQ |
Apr 01, 16:00
2.25
-0.03
(-1.12%)
After-Hours: 20:00
CNS Pharmaceuticals Total Assets (Quarterly) : 8.624M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| BioMarin Pharmaceutical, Inc. | 7.594B |
| Imunon, Inc. | 12.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.101M |
| Shareholders Equity (Quarterly) | 4.523M |
| Debt to Equity Ratio | 0.0727 |
| Current Ratio | 1.965 |
| Net Debt Paydown Yield | -1.83% |